DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/g2hdqj/gene_therapy) has announced the addition of Jain PharmaBiotech's new report "Gene Therapy - Technologies, Markets and Companies" to their offering.
Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes and DNA are now being introduced without the use of vectors and various techniques are being used to modify the function of genes in vivo without gene transfer. If one adds to this the cell therapy particularly with use of genetically modified cells, the scope of gene therapy becomes much broader. Gene therapy can now combined with antisense techniques such as RNA interference (RNAi), further increasing the therapeutic applications. This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him during the past decade including a textbook of gene therapy and a book on gene therapy companies. This report describes the setbacks of gene therapy and renewed interest in the topic
Profiles of 180 companies involved in developing gene therapy are presented along with 202 collaborations. There were only 44 companies involved in this area in 1995. In spite of some failures and mergers, the number of companies has increased more than 4-fold within a decade. These companies have been followed up since they were the topic of a book on gene therapy companies by the author of this report. John Wiley & Sons published the book in 2000 and from 2001 to 2003, updated versions of these companies (approximately 160 at mid-2003) were available on Wiley's web site. Since that free service was discontinued and the rights reverted to the author, this report remains the only authorized continuously updated version on gene therapy companies.
Benefits of this report
- Up-to-date on-stop information on gene therapy with 73 tables and 15 figures
- Evaluation of gene therapy technologies
- 740 selected references from the literature
- Estimates of gene therapy markets from 2012-2022
- Profiles of 180 companies involved and collaborations in this area
Who should read this report?
- Biotechnology companies developing gene therapy
- Academic institutions doing research in gene therapy
- Drug delivery companies
- Pharmaceutical companies interested in gene therapy
- Gene therapy companies
- Venture capital and investment companies
Key Topics Covered:
Part I: Technologies & Markets
1. Introduction
2. Gene Therapy Technologies
3. Clinical Applications of Gene Therapy
4. Gene Therapy of Genetic Disorders
5. Gene Therapy of Cancer
6. Gene Therapy of Neurological Disorders
7. Gene Therapy of Cardiovascular Disorders
8. Gene therapy of viral infections
9. Research, Development and Future of Gene Therapy
10. Regulatory, Safety and Ethical Issues of Gene Therapy
11. Markets for Gene Therapy
12. References
Part II: Companies
13. Companies involved in Gene Therapy
For more information visit http://www.researchandmarkets.com/research/g2hdqj/gene_therapy
Source: Jain PharmaBiotech